Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 58 | 279 | 14 | 110 |
| Gross Profit | N/A | 58 | 279 | 14 | 110 |
| Operating Expenses | 1,276 | 1,858 | 1,377 | 2,349 | 1,066 |
| Operating Income | -1,276 | -1,801 | -1,098 | -2,335 | -956 |
| Interest Expense | 48 | 51 | 64 | 62 | 59 |
| Pre-tax Income | -1,324 | -1,852 | -1,162 | -2,397 | -1,014 |
| Net Income Continuous | -1,324 | -1,852 | -1,162 | -2,397 | -1,014 |
| Minority Interests | -12 | -38 | N/A | N/A | N/A |
| Net Income | $-1,311 | $-1,814 | $-1,162 | $-2,397 | $-1,014 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EBITDA(a) | $-1,275 | $-1,800 | $-1,098 | $-2,334 | $-954 |